Replies to post #224631 on Biotech Values

[biotech_researcher]

BMY- CELG “Approximately 75% of BMY shareholders and 70% of CELG shareholders voted yes”

Kind of bogus numbers if you ask me. There was enough institutional resistance than that number for the BMY count would indicate..

[DewDiligence]

BMY sells $19B of debt to (partially) fund CELG acquisition; there are 9 tranches:

• $0.75B of 1-year floating-rate notes
• $0.50B of 3-year floating-rate notes
• $1.0B of 2-year notes paying 2.55%
• $1.5B of 3-year notes paying 2.60%
• $3.25B of 5-year notes paying 2.90%
• $2.25B of 7-year notes paying 3.20%
• $4.0B of 10-year notes paying 3.40%
• $2.0B of 20-year notes paying 4.125%
• $3.75B of 30-year notes paying 4.250%

https://www.businesswire.com/news/home/20190508005247/en